img

Global CAR T-Cell Therapy Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CAR T-Cell Therapy Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
CAR T-Cell Therapy Agents report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CAR T-Cell Therapy Agents market is projected to reach US$ 583.8 million in 2029, increasing from US$ 366 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Demand from Lymphoma and Multiple Myeloma are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR T-Cell Therapy Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAR T-Cell Therapy Agents market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAR T-Cell Therapy Agents introduction, etc. CAR T-Cell Therapy Agents Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CAR T-Cell Therapy Agents market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of CAR T-Cell Therapy Agents
1.1 CAR T-Cell Therapy Agents Market Overview
1.1.1 CAR T-Cell Therapy Agents Product Scope
1.1.2 CAR T-Cell Therapy Agents Market Status and Outlook
1.2 Global CAR T-Cell Therapy Agents Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CAR T-Cell Therapy Agents Market Size by Region (2018-2029)
1.4 Global CAR T-Cell Therapy Agents Historic Market Size by Region (2018-2024)
1.5 Global CAR T-Cell Therapy Agents Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CAR T-Cell Therapy Agents Market Size (2018-2029)
1.6.1 North America CAR T-Cell Therapy Agents Market Size (2018-2029)
1.6.2 Europe CAR T-Cell Therapy Agents Market Size (2018-2029)
1.6.3 Asia-Pacific CAR T-Cell Therapy Agents Market Size (2018-2029)
1.6.4 Latin America CAR T-Cell Therapy Agents Market Size (2018-2029)
1.6.5 Middle East & Africa CAR T-Cell Therapy Agents Market Size (2018-2029)
2 CAR T-Cell Therapy Agents Market by Type
2.1 Introduction
2.1.1 CD19-targeted
2.1.2 BCMA-targeted
2.2 Global CAR T-Cell Therapy Agents Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CAR T-Cell Therapy Agents Historic Market Size by Type (2018-2024)
2.2.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CAR T-Cell Therapy Agents Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CAR T-Cell Therapy Agents Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CAR T-Cell Therapy Agents Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CAR T-Cell Therapy Agents Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CAR T-Cell Therapy Agents Revenue Breakdown by Type (2018-2029)
3 CAR T-Cell Therapy Agents Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global CAR T-Cell Therapy Agents Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CAR T-Cell Therapy Agents Historic Market Size by Application (2018-2024)
3.2.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CAR T-Cell Therapy Agents Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CAR T-Cell Therapy Agents Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CAR T-Cell Therapy Agents Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CAR T-Cell Therapy Agents Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CAR T-Cell Therapy Agents Revenue Breakdown by Application (2018-2029)
4 CAR T-Cell Therapy Agents Competition Analysis by Players
4.1 Global CAR T-Cell Therapy Agents Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
4.3 Date of Key Players Enter into CAR T-Cell Therapy Agents Market
4.4 Global Top Players CAR T-Cell Therapy Agents Headquarters and Area Served
4.5 Key Players CAR T-Cell Therapy Agents Product Solution and Service
4.6 Competitive Status
4.6.1 CAR T-Cell Therapy Agents Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis CAR T-Cell Therapy Agents Products, Services and Solutions
5.1.4 Novartis CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences CAR T-Cell Therapy Agents Products, Services and Solutions
5.2.4 Gilead Sciences CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.2.5 Gilead Sciences Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Products, Services and Solutions
5.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.3.5 J & J Recent Developments
5.4 J & J
5.4.1 J & J Profile
5.4.2 J & J Main Business
5.4.3 J & J CAR T-Cell Therapy Agents Products, Services and Solutions
5.4.4 J & J CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.4.5 J & J Recent Developments
5.5 JW Therapeutics
5.5.1 JW Therapeutics Profile
5.5.2 JW Therapeutics Main Business
5.5.3 JW Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
5.5.4 JW Therapeutics CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.5.5 JW Therapeutics Recent Developments
5.6 FOSUNKite
5.6.1 FOSUNKite Profile
5.6.2 FOSUNKite Main Business
5.6.3 FOSUNKite CAR T-Cell Therapy Agents Products, Services and Solutions
5.6.4 FOSUNKite CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.6.5 FOSUNKite Recent Developments
5.7 CARsgen Therapeutics (Pipeline)
5.7.1 CARsgen Therapeutics (Pipeline) Profile
5.7.2 CARsgen Therapeutics (Pipeline) Main Business
5.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Products, Services and Solutions
5.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
5.8 CARsgen Therapeutics
5.8.1 CARsgen Therapeutics Profile
5.8.2 CARsgen Therapeutics Main Business
5.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
5.8.4 CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.8.5 CARsgen Therapeutics Recent Developments
5.9 Autolus Therapeutics
5.9.1 Autolus Therapeutics Profile
5.9.2 Autolus Therapeutics Main Business
5.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
5.9.4 Autolus Therapeutics CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.9.5 Autolus Therapeutics Recent Developments
5.10 Sorrento Therapeutics
5.10.1 Sorrento Therapeutics Profile
5.10.2 Sorrento Therapeutics Main Business
5.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
5.10.4 Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.10.5 Sorrento Therapeutics Recent Developments
5.11 Mustang Bio
5.11.1 Mustang Bio Profile
5.11.2 Mustang Bio Main Business
5.11.3 Mustang Bio CAR T-Cell Therapy Agents Products, Services and Solutions
5.11.4 Mustang Bio CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.11.5 Mustang Bio Recent Developments
5.12 Bluebird Bio
5.12.1 Bluebird Bio Profile
5.12.2 Bluebird Bio Main Business
5.12.3 Bluebird Bio CAR T-Cell Therapy Agents Products, Services and Solutions
5.12.4 Bluebird Bio CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.12.5 Bluebird Bio Recent Developments
5.13 Cellectis
5.13.1 Cellectis Profile
5.13.2 Cellectis Main Business
5.13.3 Cellectis CAR T-Cell Therapy Agents Products, Services and Solutions
5.13.4 Cellectis CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.13.5 Cellectis Recent Developments
5.14 Allogene Therapeutics
5.14.1 Allogene Therapeutics Profile
5.14.2 Allogene Therapeutics Main Business
5.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
5.14.4 Allogene Therapeutics CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.14.5 Allogene Therapeutics Recent Developments
5.15 Celyad
5.15.1 Celyad Profile
5.15.2 Celyad Main Business
5.15.3 Celyad CAR T-Cell Therapy Agents Products, Services and Solutions
5.15.4 Celyad CAR T-Cell Therapy Agents Revenue (US$ Million) & (2018-2024)
5.15.5 Celyad Recent Developments
6 North America
6.1 North America CAR T-Cell Therapy Agents Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Agents Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CAR T-Cell Therapy Agents Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CAR T-Cell Therapy Agents Market Dynamics
11.1 CAR T-Cell Therapy Agents Industry Trends
11.2 CAR T-Cell Therapy Agents Market Drivers
11.3 CAR T-Cell Therapy Agents Market Challenges
11.4 CAR T-Cell Therapy Agents Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market CAR T-Cell Therapy Agents Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global CAR T-Cell Therapy Agents Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global CAR T-Cell Therapy Agents Market Size Share by Region (2018-2024)
Table 4. Global CAR T-Cell Therapy Agents Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global CAR T-Cell Therapy Agents Forecasted Market Size Share by Region (2024-2029)
Table 6. Global CAR T-Cell Therapy Agents Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2024)
Table 9. Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global CAR T-Cell Therapy Agents Revenue Market Share by Type (2024-2029)
Table 11. North America CAR T-Cell Therapy Agents Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America CAR T-Cell Therapy Agents Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe CAR T-Cell Therapy Agents Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe CAR T-Cell Therapy Agents Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific CAR T-Cell Therapy Agents Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific CAR T-Cell Therapy Agents Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America CAR T-Cell Therapy Agents Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America CAR T-Cell Therapy Agents Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa CAR T-Cell Therapy Agents Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa CAR T-Cell Therapy Agents Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global CAR T-Cell Therapy Agents Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2024)
Table 24. Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global CAR T-Cell Therapy Agents Revenue Market Share by Application (2024-2029)
Table 26. North America CAR T-Cell Therapy Agents Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America CAR T-Cell Therapy Agents Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe CAR T-Cell Therapy Agents Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe CAR T-Cell Therapy Agents Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific CAR T-Cell Therapy Agents Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific CAR T-Cell Therapy Agents Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America CAR T-Cell Therapy Agents Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America CAR T-Cell Therapy Agents Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa CAR T-Cell Therapy Agents Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa CAR T-Cell Therapy Agents Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global CAR T-Cell Therapy Agents Revenue (US$ Million) by Players (2018-2024)
Table 37. Global CAR T-Cell Therapy Agents Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Table 39. Date of Key Players Enter into CAR T-Cell Therapy Agents Market
Table 40. Global CAR T-Cell Therapy Agents Key Players Headquarters and Area Served
Table 41. CAR T-Cell Therapy Agents Product Solution and Service
Table 42. Global CAR T-Cell Therapy Agents Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis CAR T-Cell Therapy Agents Products, Services and Solutions
Table 47. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Novartis (2018-2024)
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Basic Information List
Table 50. Gilead Sciences Description and Business Overview
Table 51. Gilead Sciences CAR T-Cell Therapy Agents Products, Services and Solutions
Table 52. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Gilead Sciences (2018-2024)
Table 53. Gilead Sciences Recent Developments
Table 54. Bristol-Myers Squibb Basic Information List
Table 55. Bristol-Myers Squibb Description and Business Overview
Table 56. Bristol-Myers Squibb CAR T-Cell Therapy Agents Products, Services and Solutions
Table 57. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Bristol-Myers Squibb (2018-2024)
Table 58. Bristol-Myers Squibb Recent Developments
Table 59. J & J Basic Information List
Table 60. J & J Description and Business Overview
Table 61. J & J CAR T-Cell Therapy Agents Products, Services and Solutions
Table 62. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of J & J (2018-2024)
Table 63. J & J Recent Developments
Table 64. JW Therapeutics Basic Information List
Table 65. JW Therapeutics Description and Business Overview
Table 66. JW Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
Table 67. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of JW Therapeutics (2018-2024)
Table 68. JW Therapeutics Recent Developments
Table 69. FOSUNKite Basic Information List
Table 70. FOSUNKite Description and Business Overview
Table 71. FOSUNKite CAR T-Cell Therapy Agents Products, Services and Solutions
Table 72. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of FOSUNKite (2018-2024)
Table 73. FOSUNKite Recent Developments
Table 74. CARsgen Therapeutics (Pipeline) Basic Information List
Table 75. CARsgen Therapeutics (Pipeline) Description and Business Overview
Table 76. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Products, Services and Solutions
Table 77. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of CARsgen Therapeutics (Pipeline) (2018-2024)
Table 78. CARsgen Therapeutics (Pipeline) Recent Developments
Table 79. CARsgen Therapeutics Basic Information List
Table 80. CARsgen Therapeutics Description and Business Overview
Table 81. CARsgen Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
Table 82. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of CARsgen Therapeutics (2018-2024)
Table 83. CARsgen Therapeutics Recent Developments
Table 84. Autolus Therapeutics Basic Information List
Table 85. Autolus Therapeutics Description and Business Overview
Table 86. Autolus Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
Table 87. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Autolus Therapeutics (2018-2024)
Table 88. Autolus Therapeutics Recent Developments
Table 89. Sorrento Therapeutics Basic Information List
Table 90. Sorrento Therapeutics Description and Business Overview
Table 91. Sorrento Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
Table 92. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Sorrento Therapeutics (2018-2024)
Table 93. Sorrento Therapeutics Recent Developments
Table 94. Mustang Bio Basic Information List
Table 95. Mustang Bio Description and Business Overview
Table 96. Mustang Bio CAR T-Cell Therapy Agents Products, Services and Solutions
Table 97. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Mustang Bio (2018-2024)
Table 98. Mustang Bio Recent Developments
Table 99. Bluebird Bio Basic Information List
Table 100. Bluebird Bio Description and Business Overview
Table 101. Bluebird Bio CAR T-Cell Therapy Agents Products, Services and Solutions
Table 102. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Bluebird Bio (2018-2024)
Table 103. Bluebird Bio Recent Developments
Table 104. Cellectis Basic Information List
Table 105. Cellectis Description and Business Overview
Table 106. Cellectis CAR T-Cell Therapy Agents Products, Services and Solutions
Table 107. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Cellectis (2018-2024)
Table 108. Cellectis Recent Developments
Table 109. Allogene Therapeutics Basic Information List
Table 110. Allogene Therapeutics Description and Business Overview
Table 111. Allogene Therapeutics CAR T-Cell Therapy Agents Products, Services and Solutions
Table 112. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Allogene Therapeutics (2018-2024)
Table 113. Allogene Therapeutics Recent Developments
Table 114. Celyad Basic Information List
Table 115. Celyad Description and Business Overview
Table 116. Celyad CAR T-Cell Therapy Agents Products, Services and Solutions
Table 117. Revenue (US$ Million) in CAR T-Cell Therapy Agents Business of Celyad (2018-2024)
Table 118. Celyad Recent Developments
Table 119. North America CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 120. North America CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 121. Europe CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 122. Europe CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 123. Asia-Pacific CAR T-Cell Therapy Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2018-2024) & (US$ Million)
Table 125. Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2024-2029) & (US$ Million)
Table 126. Asia-Pacific CAR T-Cell Therapy Agents Market Share by Region (2018-2024)
Table 127. Asia-Pacific CAR T-Cell Therapy Agents Market Share by Region (2024-2029)
Table 128. Latin America CAR T-Cell Therapy Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 129. Latin America CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 130. Latin America CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 131. Middle East & Africa CAR T-Cell Therapy Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 132. Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 133. Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 134. CAR T-Cell Therapy Agents Market Trends
Table 135. CAR T-Cell Therapy Agents Market Drivers
Table 136. CAR T-Cell Therapy Agents Market Challenges
Table 137. CAR T-Cell Therapy Agents Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Agents Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global CAR T-Cell Therapy Agents Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global CAR T-Cell Therapy Agents Market Share by Regions: 2022 VS 2029
Figure 4. Global CAR T-Cell Therapy Agents Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America CAR T-Cell Therapy Agents Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe CAR T-Cell Therapy Agents Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific CAR T-Cell Therapy Agents Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America CAR T-Cell Therapy Agents Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa CAR T-Cell Therapy Agents Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CD19-targeted
Figure 11. Global CD19-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of BCMA-targeted
Figure 13. Global BCMA-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global CAR T-Cell Therapy Agents Market Size Share by Type: 2022 & 2029
Figure 15. North America CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2029)
Figure 16. Europe CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2029)
Figure 18. Latin America CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2029)
Figure 20. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Multiple Myeloma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global CAR T-Cell Therapy Agents Market Size Share by Application: 2022 & 2029
Figure 23. North America CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2029)
Figure 24. Europe CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2029)
Figure 26. Latin America CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2029)
Figure 28. CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players CAR T-Cell Therapy Agents Market Share in 2022
Figure 30. North America CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 31. United States CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 32. Canada CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 33. Germany CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 34. France CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 36. Italy CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 37. Russia CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific CAR T-Cell Therapy Agents Market Share by Region (2018-2029)
Figure 40. China CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 41. Japan CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 44. India CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 45. Australia CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 47. Mexico CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 50. Turkey CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 52. UAE CAR T-Cell Therapy Agents Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries